Cidofovir injection
Products billed under this code include Cidofovir.
Payment limit per 375 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Cidofovir.
Payment limit per 375 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Cidofovir | Heritage Pharmaceuticals Inc. | 23155-0216-31 | 1 | $522.238 |
| Cidofovir | Mylan Institutional LLC | 67457-0210-05 | 1 | $522.238 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $522.238 | −$13.497 | 375 MG | Cidofovir injection | v1, posted September 17, 2026 |
| 3Q26 | $535.735 | −$25.054 | 375 MG | Cidofovir injection | v1, posted September 15, 2026 |
| 2Q26 | $560.789 | +$36.306 | 375 MG | Cidofovir injection | v1, posted September 15, 2026 |
| 1Q26 | $524.483 | −$21.811 | 375 MG | Cidofovir injection | v1, posted September 15, 2026 |
| 4Q25 | $546.294 | +$16.919 | 375 MG | Cidofovir injection | v1, posted September 8, 2026 |
| 3Q25 | $529.375 | +$7.548 | 375 MG | Cidofovir injection | v1, posted March 10, 2026 |
| 2Q25 | $521.827 | +$220.724 | 375 MG | Cidofovir injection | v1, posted March 10, 2026 |
| 1Q25 | $301.103 | −$226.899 | 375 MG | Cidofovir injection | v1, posted December 19, 2025 |
| 4Q24 | $528.002 | −$16.732 | 375 MG | Cidofovir injection | v1, posted June 11, 2025 |
| 3Q24 | $544.734 | −$36.323 | 375 MG | Cidofovir injection | v1, posted June 11, 2025 |
| 2Q24 | $581.057 | +$26.865 | 375 MG | Cidofovir injection | v1, posted March 11, 2025 |
| 1Q24 | $554.192 | +$3.816 | 375 MG | Cidofovir injection | v1, posted December 19, 2024 |
| 4Q23 | $550.376 | −$26.655 | 375 MG | Cidofovir injection | v1, posted October 10, 2024 |
| 3Q23 | $577.031 | −$31.296 | 375 MG | Cidofovir injection | v1, posted June 5, 2024 |
| 2Q23 | $608.327 | −$21.448 | 375 MG | Cidofovir injection | v1, posted February 23, 2024 |
| 1Q23 | $629.775 | +$12.204 | 375 MG | Cidofovir injection | v1, posted December 6, 2023 |
| 4Q22 | $617.571 | +$34.56 | 375 MG | Cidofovir injection | v1, posted June 22, 2023 |
| 3Q22 | $583.011 | +$36.808 | 375 MG | Cidofovir injection | v1, posted June 9, 2023 |
| 2Q22 | $546.203 | −$21.719 | 375 MG | Cidofovir injection | v1, posted December 14, 2022 |
| 1Q22 | $567.922 | +$4.162 | 375 MG | Cidofovir injection | v1, posted June 8, 2022 |
| 4Q21 | $563.76 | −$26.024 | 375 MG | Cidofovir injection | v1, posted June 2, 2022 |
| 3Q21 | $589.784 | −$33.494 | 375 MG | Cidofovir injection | v1, posted June 2, 2022 |
| 2Q21 | $623.278 | +$32.987 | 375 MG | Cidofovir injection | v1, posted March 1, 2022 |
| 1Q21 | $590.291 | – | 375 MG | Cidofovir injection | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.